Critical issues in mucosal immunity for HIV-1 vaccine development
Open Access
- 31 July 2008
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 122 (1) , 3-9
- https://doi.org/10.1016/j.jaci.2008.03.036
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionProceedings of the National Academy of Sciences, 2008
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?The Journal of Experimental Medicine, 2008
- High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavageMucosal Immunology, 2007
- A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120Virology, 2007
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- HIV-1 immunopathogenesis: How good interferon turns badClinical Immunology, 2006
- Genomics meets HIV-1Nature Reviews Microbiology, 2006
- Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged MonkeysScience, 2006
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005